<p>Last week, President Donald Trump announced a deal with pharmaceutical company Merck KGaA and its U.S. subsidiary, EMD Serono, to sharply reduce the cost of some fertility drugs used for in-vitro fertilization, in exchange for a three-year reprieve on some of the tariffs levied on pharmaceutical imports (The Cancer Letter, Oct. 24, 2025). This content […]</p> <p>The post <a href="https://cancerletter.com/cancer-policy/20251031_5c/"…
Senators, nonprofits respond to Trump’s avowed support for IVF
The Cancer Letter | | The Cancer Letter Administrator
Topics: oncology